ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

OCUP Company Profile and Key Details

NASDAQ : OCUP

Ocuphire Pharma, Inc.

$1.17

-0.16-12.03%

Open: 4:00 PM

Not Actively Trading

64.8

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

OCUP Stock Price Chart

Stock Price Today

Ocuphire Pharma, Inc. (OCUP) stock declined over -12.03%, trading at $1.17 on NASDAQ, down from the previous close of $1.33. The stock opened at $1.33, fluctuating between $1.07 and $1.36 in the recent session.

Stock Snapshot

1.33

Prev. Close

1.33

Open

31.74M

Market Cap

27.13M

Number of Shares

1.0715

Day Low

1.36

Day High

-2.1666666666666665

P/E Ratio

90.39%

Free Float in %

-0.54

EPS (TTM)

2.17

Book Value

-0.05

Cash Flow per Share

675.97K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Nov 20, 2024	0.95	0.98	0.91	0.98	209.86K
Nov 19, 2024	0.92	0.94	0.85	0.88	265.74K
Nov 18, 2024	1.05	1.07	0.88	0.91	599.73K
Nov 15, 2024	1.07	1.07	0.97	1.06	292.89K
Nov 14, 2024	1.09	1.14	1.05	1.06	172.07K
Nov 13, 2024	1.15	1.15	1.07	1.08	235.14K
Nov 12, 2024	1.12	1.18	1.12	1.14	151.4K
Nov 11, 2024	1.13	1.18	1.11	1.17	123.59K
Nov 08, 2024	1.17	1.17	1.10	1.12	183.56K
Nov 07, 2024	1.17	1.18	1.09	1.09	296.93K
Nov 06, 2024	1.17	1.18	1.12	1.17	180.61K
Nov 05, 2024	1.17	1.19	1.16	1.16	62.55K
Nov 04, 2024	1.17	1.20	1.16	1.17	73.89K
Nov 01, 2024	1.19	1.22	1.16	1.18	118.47K
Oct 31, 2024	1.26	1.33	1.18	1.20	132.89K
Oct 30, 2024	1.30	1.33	1.25	1.25	106.12K
Oct 29, 2024	1.36	1.36	1.30	1.33	88.51K
Oct 28, 2024	1.20	1.35	1.18	1.35	231.02K
Oct 25, 2024	1.20	1.20	1.14	1.17	205.83K
Oct 24, 2024	1.19	1.20	1.10	1.13	177.13K

Contact Details

Farmington Hills, MI 48335

United States

Website: https://www.ocuphire.comContact: 248 681 9815

About Company

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.

Frequently Asked Questions

What is the current Ocuphire Pharma, Inc. (OCUP) stock price?

Ocuphire Pharma, Inc. (NASDAQ: OCUP) stock price is $1.17 in the last trading session. During the trading session, OCUP stock reached the peak price of $1.36 while $1.07 was the lowest point it dropped to. The percentage change in OCUP stock occurred in the recent session was -12.03% while the dollar amount for the price change in OCUP stock was -$0.16.

OCUP's industry and sector of operation?

The NASDAQ listed OCUP is part of Biotechnology industry that operates in the broader Healthcare sector. Ocuphire Pharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of OCUP?

Ms. Bindu Manne
Head of Market Devel. & Commercialization
Mr. Erik Sims
Director & Corporation Controller
Mr. Richard J. Rodgers M.B.A.
Interim Chief Executive Officer, Interim Pres & Director
Dr. Mitchell Brigell Ph.D.
Head of Clinical Devel. & Strategy
Dr. Daniela C. Oniciu Ph.D.
Global Head of R&D, Chemistry and Product Devel.
Mr. Chris Ernst
Global Head of QA & Manufacturing
Ms. Mina Patel Sooch M.B.A., MBA
Founder, Treasurer & Director
Ms. Amy Zaremba Rabourn C.P.A., CPA, MAcc
Senior Vice President of Fin.
Mr. Ronil A Patel M.S.
Vice President of Bus. Devel. & Market Strategy
Mr. Bernhard Hoffmann M.B.A.
Senior Vice President of Corporation Devel. & Operations and Sec.

How OCUP did perform over past 52-week?

OCUP's closing price is 9.19% higher than its 52-week low of $1.07 where as its distance from 52-week high of $3.40 is -65.58%.

How many employees does OCUP have?

Number of OCUP employees currently stands at 14.

Link for OCUP official website?

Official Website of OCUP is: https://www.ocuphire.com

How do I contact OCUP?

OCUP could be contacted at phone 248 681 9815 and can also be accessed through its website. OCUP operates from 37000 Grand River Avenue, Farmington Hills, MI 48335, United States.

How many shares of OCUP are traded daily?

OCUP stock volume for the day was 675.97K shares. The average number of OCUP shares traded daily for last 3 months was 139.15K.

What is the market cap of OCUP currently?

The market value of OCUP currently stands at $31.74M with its latest stock price at $1.17 and 27.13M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	14
Beta	0.31
Sales or Revenue	$19.05M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology